Meeting
2021 ASCO Annual Meeting
Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.
Authors
Andrew Oar
Gold Coast University Hospital, Southport, Australia
Andrew Oar , Andrew Kneebone , Mark Lee , David Goldstein , Katrin Marie Sjoquist , Hien Le , Julie Chu , Andrew Barbour , Leily Gholamrezaei , James F. Lynam , Andrej Bece , Sandra Bahamad , Sonia Yip , David Espinoza , Lorraine A. Chantrill , Alisha Moore , Dominique Lee , Quoc Nam Nguyen , Jaswinder Samra , No Firstname Jan.Mumford@Tics.Com.Au
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Clinical Trial Registration Number
ACTRN12619000409178
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr TPS4172)
DOI
10.1200/JCO.2021.39.15_suppl.TPS4172
Abstract #
TPS4172
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC): A randomized phase 3 multicenter study.
First Author: Michael J. Pishvaian
Poster
2021 ASCO Annual Meeting
A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).
First Author: Valerie Lee
Poster
2020 ASCO Virtual Scientific Program
A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT).
First Author: Anna M. Varghese
Poster
2020 Gastrointestinal Cancers Symposium
A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.
First Author: Pashtoon Murtaza Kasi